GlassScriptPhysician profile
Derek Alan Barker
NPI 1649408998
$1,980.31
in general payments reported to CMS, 2019-2025
23 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $479 · 2023: $509 · 2024: $287 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $781.74 | 2021-2025 | Biofoam, Prostep Mica, Ortholoc 3di |
| Vilex LLC | $210.51 | 2025 | Dynex |
| Treace Medical Concepts, INC. | $184.02 | 2021-2025 | |
| Paragon 28, INC. | $94.21 | 2021 | |
| Paratek Pharmaceuticals, INC. | $72.72 | 2022 | |
| Horizon Therapeutics Plc | $71.25 | 2022-2023 | Krystexxa |
| Smith+Nephew, INC. | $66.14 | 2022-2024 | |
| Kerecis Limited | $64.66 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $54.49 | 2022 | |
| Amgen INC. | $51.78 | 2024-2025 | Krystexxa |
| Nevro Corp. | $49.06 | 2022-2024 | Senza |
| Organogenesis INC. | $32.22 | 2021-2022 | |
| Bioventus LLC | $30.94 | 2023 | Exogen Ultrasound Bone Healing System |
| In2bones USA, LLC | $28.35 | 2022 | |
| Nabriva Therapeutics, Plc | $27.81 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $24.77 | 2025 | Senza |
| Abbvie INC. | $24.44 | 2022 | |
| Orthofix Medical, INC. | $23.21 | 2021 | |
| Medtronic, INC. | $21.33 | 2023 | Intellis Adaptivestim |
| Heron Therapeutics, INC. | $20.62 | 2022 | |
| Averitas Pharma INC. | $19.81 | 2023 | Qutenza |
| Innovation Technologies INC | $13.96 | 2025 | Irrisept |
| Forte Bio-Pharma LLC | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.